Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management

OncoTargets and Therapy ◽

10.2147/ott.s3480 ◽

2009 ◽

pp. 87 ◽

Author(s):

Kathryn Schuff ◽

Gramza

Keyword(s):

Thyroid Cancer ◽

Thyroid Stimulating Hormone ◽

Human Thyroid ◽

Cancer Management ◽

Stimulating Hormone

Download Full-text

Recombinant human thyroid-stimulating hormone as an alternative for thyroid hormone withdrawal in thyroid cancer management

Current Opinion in Oncology ◽

10.1097/cco.0b013e3283339d5d ◽

2010 ◽

Vol 22 (1) ◽

pp. 6-10 ◽

Author(s):

Ming-Kai Chen ◽

Indukala Doddamane ◽

David W Cheng

Keyword(s):

Thyroid Cancer ◽

Thyroid Hormone ◽

Thyroid Stimulating Hormone ◽

Human Thyroid ◽

Thyroid Hormone Withdrawal ◽

Cancer Management ◽

Stimulating Hormone

Download Full-text

Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective

Endocrinology and Metabolism ◽

10.3803/enm.2015.30.4.531 ◽

2015 ◽

Vol 30 (4) ◽

pp. 531 ◽

Author(s):

Seo Young Sohn ◽

Hye Won Jang ◽

Yoon Young Cho ◽

Sun Wook Kim ◽

Jae Hoon Chung

Keyword(s):

Thyroid Cancer ◽

Economic Evaluation ◽

Thyroid Hormone ◽

Thyroid Stimulating Hormone ◽

Human Thyroid ◽

Thyroid Hormone Withdrawal ◽

Hormone Stimulation ◽

Radioiodine Ablation ◽

Stimulating Hormone

Download Full-text

INITIAL ADOPTION OF RECOMBINANT HUMAN THYROID-STIMULATING HORMONE FOLLOWING THYROIDECTOMY IN THE MEDICARE THYROID CANCER PATIENT POPULATION

Endocrine Practice ◽

10.4158/ep-2018-0253 ◽

2019 ◽

Vol 25 (1) ◽

pp. 31-42

Author(s):

Michaela A. Dinan ◽

Yanhong Li ◽

Shelby D. Reed ◽

Julie Ann Sosa

Keyword(s):

Thyroid Cancer ◽

Cancer Patient ◽

Patient Population ◽

Thyroid Stimulating Hormone ◽

Human Thyroid ◽

Thyroid Cancer Patient ◽

Stimulating Hormone

Download Full-text

Absence of Bone Marrow Toxicity in Elderly Patients Treated With Recombinant Human Thyroid-stimulating Hormone and Empirically Dosed Radioiodine for Thyroid Cancer

American Journal of Clinical Oncology ◽

10.1097/coc.0b013e318248d67c ◽

2013 ◽

Vol 36 (4) ◽

pp. 348-353 ◽

Author(s):

Robert J. Amdur ◽

Tu Dan ◽

Ernest Mazzaferri

Keyword(s):

Bone Marrow ◽

Thyroid Cancer ◽

Elderly Patients ◽

Thyroid Stimulating Hormone ◽

Human Thyroid ◽

Bone Marrow Toxicity ◽

Stimulating Hormone

Download Full-text

The effect of recombinant human thyroid stimulating hormone on sustaining liver and renal function in thyroid cancer patients during radioactive iodine therapy

Nuclear Medicine Communications ◽

10.1097/mnm.0000000000000118 ◽

2014 ◽

Vol 35 (7) ◽

pp. 727-732 ◽

Author(s):

Soo Jin Lee ◽

Ho-Young Lee ◽

Won Woo Lee ◽

Sang Eun Kim

Keyword(s):

Renal Function ◽

Thyroid Cancer ◽

Cancer Patients ◽

Radioactive Iodine ◽

Thyroid Stimulating Hormone ◽

Human Thyroid ◽

Radioactive Iodine Therapy ◽

Stimulating Hormone

Download Full-text

The HiLo Trial: a Multicentre Randomised Trial of High- versus Low-dose Radioiodine, with or without Recombinant Human Thyroid Stimulating Hormone, for Remnant Ablation after Surgery for Differentiated Thyroid Cancer

Clinical Oncology ◽

10.1016/j.clon.2008.03.010 ◽

2008 ◽

Vol 20 (5) ◽

pp. 325-326 ◽

Author(s):

U. Mallick ◽

C. Harmer ◽

A. Hackshaw

Keyword(s):

Thyroid Cancer ◽

Differentiated Thyroid Cancer ◽

Low Dose ◽

Randomised Trial ◽

Thyroid Stimulating Hormone ◽

Human Thyroid ◽

Remnant Ablation ◽

Stimulating Hormone

Download Full-text

Influence of recombinant human thyroid-stimulating hormone of and radioiodine therapy on the function of cells of innate immunity in patients with thyroid cancer

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY ◽

10.22141/2224-0721.14.6.2018.146068 ◽

2018 ◽

Vol 14 (6) ◽

pp. 579-584

Author(s):

T.F. Zakharchenko ◽

G.A. Zamotaeva ◽

S.V. Gulevatyi

Keyword(s):

Innate Immunity ◽

Thyroid Cancer ◽

Radioiodine Therapy ◽

Thyroid Stimulating Hormone ◽

Human Thyroid ◽

Stimulating Hormone

Download Full-text

Treatment of Scan-Negative, Thyroglobulin-Positive Metastatic Thyroid Cancer Using Radioiodine 131I and Recombinant Human Thyroid Stimulating Hormone--Authors' Responseh

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.82.12.4277-b ◽

1997 ◽

Vol 82 (12) ◽

pp. 4277b-4278 ◽

Author(s):

A. Z. Rudavsky

Keyword(s):

Thyroid Cancer ◽

Thyroid Stimulating Hormone ◽

Human Thyroid ◽

Metastatic Thyroid Cancer ◽

Stimulating Hormone

Download Full-text

Multicentre randomised trial of High dose versus Low dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation following surgery for differentiated thyroid cancer

http://isrctn.org/> ◽

10.1186/isrctn56078540 ◽

2013 ◽

Author(s):

Pablo Alvarez

Keyword(s):

Thyroid Cancer ◽

Differentiated Thyroid Cancer ◽

Low Dose ◽

Randomised Trial ◽

Thyroid Stimulating Hormone ◽

Human Thyroid ◽

High Dose ◽

Remnant Ablation ◽

Stimulating Hormone

Download Full-text

Comparison of effective I-131 half-life between thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone for thyroid cancer: A retrospective study

Journal of Medical Imaging and Radiation Oncology ◽

10.1111/1754-9485.12238 ◽

2014 ◽

Vol 59 (2) ◽

pp. 248-254 ◽

Author(s):

Solveig Grenfell ◽

Daniel Roos ◽

James Rijken ◽

Braden Higgs ◽

Ian Kirkwood

Keyword(s):

Thyroid Cancer ◽

Retrospective Study ◽

Thyroid Hormone ◽

Half Life ◽

Thyroid Stimulating Hormone ◽

Human Thyroid ◽

Thyroid Hormone Withdrawal ◽

Stimulating Hormone

Download Full-text